Coreg and Daypro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coreg (carvedilol) and Daypro (oxaprozin). Common drug interactions include multiple injuries among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Coreg and Daypro. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Coreg?

Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,583 Coreg users. Check the latest studies of Coreg.

What is Daypro?

Daypro has active ingredients of oxaprozin. It is often used in osteoarthritis. eHealthMe is studying from 2,883 Daypro users. Check the latest studies of Daypro.



On Aug, 09, 2026

33 people who take Coreg and Daypro together, and have interactions are studied.

Coreg and Daypro drug interactions.

What are the common drug interactions of Coreg and Daypro, by gender? *:

female:

  1. Multiple injuries
  2. Nail dystrophy (bed formation of nail)
  3. Neuropathy peripheral (surface nerve damage)
  4. Onychomycosis (fungal infection of the nail)
  5. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  6. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  7. Seborrhoeic keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest)
  8. Sinus bradycardia (an unusually slow heartbeat due to heart disease)
  9. Staphylococcal infection (an infection with staphylococcus bacteria)
  10. Telangiectasia (small dilated blood vessels near the surface of the skin)

male:

  1. Cardiac failure congestive
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Chest pain
  4. Chronic kidney disease
  5. Death
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Heart rate decreased
  8. Hypertensive heart disease
  9. Hypoglycaemia (deficiency of glucose in the bloodstream)
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Coreg and Daypro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cardiac failure
  2. Renal failure acute on chronic (rapid or long lasting kidney failure)

40-49:

n/a

50-59:

  1. Dehydration (dryness resulting from the removal of water)
  2. Diabetes mellitus inadequate control
  3. Dry eye (lack of adequate tears)
  4. Escherichia infection (bacterial infection by escherichia coli)
  5. Eye injury
  6. Eyelid ptosis (falling of the upper or lower eyelid)
  7. Foot fracture
  8. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  9. Hyperhidrosis (abnormally increased sweating)
  10. Hyperkeratosis (thickening of the outer layer of the skin)

60+:

  1. Cardiac failure congestive
  2. Aphasia (damage to the parts of the brain that control language)
  3. Gastric ph decreased
  4. Gastritis (inflammation of stomach)
  5. Gout (uric acid crystals building up in the body)
  6. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  7. Hemiparesis (weakness on one side of the body)
  8. Hyperlipidaemia (presence of excess lipids in the blood)
  9. Infection
  10. Insomnia (sleeplessness)

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 13 people, 39.39%
  2. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 10 people, 30.30%
  3. Sleep Disorder: 10 people, 30.30%
  4. Gastric Ulcer (stomach ulcer): 10 people, 30.30%
  5. Allergic Rhinitis: 10 people, 30.30%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 9.09%
  7. Insomnia (sleeplessness): 3 people, 9.09%
  8. Cardiac Failure Congestive: 3 people, 9.09%
  9. Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 9.09%
  10. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg and Daypro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Coreg and Daypro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Coreg:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Daypro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Coreg and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Daypro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on carvedilol and oxaprozin (the active ingredients of Coreg and Daypro, respectively), and Coreg and Daypro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: